Cellular effects of factor VII activating protease (FSAP)

Thromb Res. 2020 Apr:188:74-78. doi: 10.1016/j.thromres.2020.02.010. Epub 2020 Feb 13.

Abstract

Factor VII activating protease (FSAP) is a circulating serine protease of broad specificity that is likely to be involved in many pathophysiological processes. The activation of the circulating zymogen form of FSAP by histones, released from damaged cells, underlines its roles in regulating host responses to tissue damage and inflammation. Some of the direct cellular effects of FSAP are mediated through protease-activated receptors (PARs). Knock-down of each one of the four PARs in endothelial cells indicated that PAR-1 and -3 are involved in regulating endothelial permeability in response to FSAP. Overexpression of PARs in cell lines led to the conclusion that PAR-2 and -1 were the main receptors for FSAP. Studies with synthetic peptides and receptor mutants demonstrate that FSAP cleaves PAR-1 and -2 at their canonical cleavage site. However, PAR-1 is not activated by FSAP in all cells, which may be related to other, as yet, undefined factors. Inhibition of apoptosis by FSAP is mediated through PAR-1 and was observed in neurons, astrocytes and A549 cells. FSAP also mediates cellular effects by modulating the activity of growth factors, generation of bradykinin, C5a and C3a generation or histone inactivation. These cellular effects need to be further investigated at the in vivo level.

Keywords: Bradykinin; Complement; FSAP; Growth factors; HABP2; Histones; Protease activated receptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Endothelial Cells
  • Factor VII*
  • Peptide Hydrolases*
  • Receptor, PAR-1 / genetics
  • Serine Endopeptidases / genetics

Substances

  • Receptor, PAR-1
  • Factor VII
  • Peptide Hydrolases
  • HABP2 protein, human
  • Serine Endopeptidases